VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 201 filers reported holding VAXCYTE INC in Q3 2023. The put-call ratio across all filers is 0.83 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,472,157 | -10.7% | 499,650 | -12.5% | 2.35% | -25.9% |
| Q2 2023 | $28,528,225 | +100.2% | 571,250 | +50.2% | 3.17% | +114.8% |
| Q1 2023 | $14,251,770 | -23.4% | 380,250 | -2.0% | 1.48% | -44.7% |
| Q4 2022 | $18,602,203 | +130.9% | 387,950 | +15.6% | 2.67% | +143.7% |
| Q3 2022 | $8,056,000 | -0.1% | 335,650 | -9.4% | 1.10% | -13.0% |
| Q2 2022 | $8,065,000 | +1.7% | 370,650 | +12.9% | 1.26% | +23.0% |
| Q1 2022 | $7,930,000 | +13.1% | 328,350 | +11.4% | 1.02% | +45.7% |
| Q4 2021 | $7,012,000 | -22.3% | 294,750 | -17.1% | 0.70% | -50.1% |
| Q3 2021 | $9,023,000 | +6.7% | 355,650 | -5.3% | 1.41% | +8.2% |
| Q2 2021 | $8,456,000 | +45.8% | 375,650 | +27.9% | 1.30% | +24.4% |
| Q1 2021 | $5,800,000 | – | 293,650 | – | 1.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 4,168,718 | $100,049,000 | 34.21% |
| Medicxi Ventures Management (Jersey) Ltd | 1,887,478 | $45,299,000 | 18.86% |
| Pivotal bioVenture Partners Investment Advisor LLC | 776,039 | $18,625,000 | 6.81% |
| Kynam Capital Management, LP | 698,638 | $16,767,000 | 3.53% |
| GREAT POINT PARTNERS LLC | 600,000 | $14,400,000 | 3.47% |
| Frazier Life Sciences Management, L.P. | 1,547,405 | $37,138,000 | 2.86% |
| Ghost Tree Capital, LLC | 360,000 | $8,640,000 | 2.42% |
| RA Capital Management | 4,581,203 | $109,949,000 | 2.35% |
| Opaleye Management Inc. | 190,000 | $4,560,000 | 1.88% |
| TPG GP A, LLC | 3,285,504 | $78,852,000 | 1.29% |